Skip to main content
SpringerPlus
Fig. 2 | SpringerPlus

Fig. 2

From: Simeprevir with peginterferon/ribavirin for patients with hepatitis C virus genotype 1: high frequency of viral relapse in elderly patients

Fig. 2

The proportions of EOT, SVR4, and SVR12 achievement in all patients, treatment-naïve patients, relapsers, and non-responders are shown. EOT, undetectable HCV RNA at the end of treatment; SVR4, undetectable HCV-RNA at the end of treatment and 4 weeks after the last treatment; SVR12, undetectable HCV-RNA at the end of treatment and 12 weeks after the last treatment

Back to article page